Kiromic BioPharma, Inc. (KRBP)
KRBP has a market cap or net worth of $314,615. The enterprise value is $7.29 million.
The last earnings date was Monday, November 13, 2023, after market close.
|Earnings Date||Nov 13, 2023|
KRBP has 1.26 million shares outstanding. The number of shares has increased by 125.37% in one year.
|Shares Change (YoY)||+125.37%|
|Shares Change (QoQ)||+12.87%|
|Owned by Insiders (%)||3.91%|
|Owned by Institutions (%)||68.50%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 0.34
|Debt / Equity||n/a|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||-170.58%|
|Return on Capital (ROIC)||-313.90%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$783,229|
In the past 12 months, KRBP has paid $3.52 million in taxes.
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -96.23% in the last 52 weeks. The beta is 0.64, so KRBP's price volatility has been lower than the market average.
|52-Week Price Change||-96.23%|
|50-Day Moving Average||0.28|
|200-Day Moving Average||2.60|
|Relative Strength Index (RSI)||47.87|
|Average Volume (30 Days)||20,633|
Short Selling Information
The latest short interest is 45,741, so 3.63% of the outstanding shares have been sold short.
|Short Previous Month||49,807|
|Short % of Shares Out||3.63%|
|Short % of Float||7.98%|
|Short Ratio (days to cover)||1.45|
|Earnings Per Share (EPS)||-$30.08|
The company has $4.38 million in cash and $11.35 million in debt, giving a net cash position of -$6.97 million or -$5.54 per share.
|Cash & Cash Equivalents||4.38M|
|Net Cash Per Share||-$5.54|
|Equity / Book Value||-4.49M|
|Book Value Per Share||-3.57|
In the last 12 months, operating cash flow was -$19.92 million and capital expenditures -$154,700, giving a free cash flow of -$20.08 million.
|Operating Cash Flow||-19.92M|
|Free Cash Flow||-20.08M|
|FCF Per Share||-$16.87|
Dividends & Yields
KRBP does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
|Price Target Difference||n/a|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
The last stock split was on March 13, 2023. It was a reverse split with a ratio of 1:30.
|Last Split Date||Mar 13, 2023|